ABC transporters in lipid transport

Smit, 1993, Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease, Cell, 75, 451, 10.1016/0092-8674(93)90380-9

Ruetz, 1994, Phosphatidylcholine translocase: a physiological role for the mdr2 gene, Cell, 77, 1071, 10.1016/0092-8674(94)90446-4

Smith, 1994, The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice, FEBS Lett., 354, 263, 10.1016/0014-5793(94)01135-4

Ruetz, 1995, Enhancement of Mdr2-mediated phosphatidylcholine translocation by the bile salt taurocholate, J. Biol. Chem., 270, 25388, 10.1074/jbc.270.43.25388

van Helvoort, 1996, MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine, Cell, 87, 507, 10.1016/S0092-8674(00)81370-7

Kino, 1996, Aureobasidin A, an antifungal cyclic depsipeptide antibiotic, is a substrate for both human MDR1 and MDR2/P-glycoproteins, FEBS Lett., 399, 29, 10.1016/S0014-5793(96)01265-3

Higgins, 1992, ABC transporters: from microorganisms to man, Annu. Rev. Cell Biol., 8, 67, 10.1146/annurev.cb.08.110192.000435

Kaur, 1998, Biochemical coupling between the DrrA and DrrB proteins of the doxorubicin efflux pomp of Streptomyces peucetius, J. Biol. Chem., 273, 17933, 10.1074/jbc.273.28.17933

Saier, 1998, Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria, FASEB J., 12, 265, 10.1096/fasebj.12.3.265

Van Veen, 1996, Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1, Proc. Natl. Acad. Sci. USA, 93, 10668, 10.1073/pnas.93.20.10668

Bolhuis, 1996, Multidrug resistance in Lactococcus lactis: evidence for ATP-dependent drug extrusion from the inner leaflet of the cytoplasmic membrane, EMBO J., 15, 4239, 10.1002/j.1460-2075.1996.tb00798.x

Regev, 1997, Flip-flop of doxorubicin across erythrocyte and lipid membranes, Biochem. Pharmacol., 54, 1151, 10.1016/S0006-2952(97)00326-2

Higgins, 1992, Is the multidrug transporter a flippase?, Trends Biochem. Sci., 17, 18, 10.1016/0968-0004(92)90419-A

Van Veen, 1998, A bacterial antibiotic-resistance gene that complements the human multidrug-resistance P-glycoprotein gene, Nature, 391, 291, 10.1038/34669

Rosenberg, 1997, Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis, J. Biol. Chem., 272, 10685, 10.1074/jbc.272.16.10685

Higgins, 1997, Structure of the multidrug resistance P-glycoprotein, Semin. Cancer Biol., 8, 135, 10.1006/scbi.1997.0067

Gottesman, 1993, Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu. Rev. Biochem., 62, 385, 10.1146/annurev.bi.62.070193.002125

Senior, 1995, The catalytic cycle of P-glycoprotein, FEBS Lett., 377, 285, 10.1016/0014-5793(95)01345-8

Stein, 1997, Kinetics of the multidrug transporter (P-glycoprotein) and its reversal, Physiol. Rev., 77, 545, 10.1152/physrev.1997.77.2.545

Shapiro, 1997, Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities, Eur. J. Biochem., 250, 130, 10.1111/j.1432-1033.1997.00130.x

Cole, 1992, Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line, Science, 258, 1650, 10.1126/science.1360704

Deeley, 1997, Function, evolution and structure of multidrug resistance protein (MRP), Semin. Cancer Biol., 8, 193, 10.1006/scbi.1997.0070

Kool, 1997, Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologs of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines, Cancer Res., 57, 3537

Borst, 1997, Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?, Semin. Cancer Biol., 8, 205, 10.1006/scbi.1997.0071

Kool, 1999, Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells, Cancer Res., 59, 175

Evers, 1998, Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA, J. Clin. Invest., 101, 1310, 10.1172/JCI119886

Kool, 1999, MRP3, an organic anion transporter able to transport anti-cancer drugs, Proc. Natl. Acad. Sci. USA, 96, 6914, 10.1073/pnas.96.12.6914

König, 1999, Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane, Hepatology, 29, 1156, 10.1002/hep.510290404

Kiuchi, 1998, cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3), FEBS Lett., 433, 149, 10.1016/S0014-5793(98)00899-0

Bakos, 1996, Membrane topology and glycosylation of the human multidrug resistance-associated protein, J. Biol. Chem., 271, 12322, 10.1074/jbc.271.21.12322

Tusnády, 1997, Membrane topology distinguishes a subfamily of the ATP-binding cassette (ABC) transporters, FEBS Lett., 402, 1, 10.1016/S0014-5793(96)01478-0

Kast, 1997, Topology mapping of the amino-terminal half of multidrug resistance-associated protein by epitope insertion and immunofluorescence, J. Biol. Chem., 272, 26479, 10.1074/jbc.272.42.26479

Bakos, 1998, Functional multidrug resistance protein (MRP) lacking the N-terminal transmembrane domain, J. Biol. Chem., 273, 32167, 10.1074/jbc.273.48.32167

Müller, 1994, Overexpression of the multidrug resistance associated protein (MRP) gene results in increased ATP-dependent glutathione S-conjugate transport, Proc. Natl. Acad. Sci. USA, 91, 13033, 10.1073/pnas.91.26.13033

Leier, 1994, The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates, J. Biol. Chem., 269, 27807, 10.1016/S0021-9258(18)46856-1

Jedlitschky, 1994, ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein, Cancer Res., 54, 4833

Jedlitschky, 1996, Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump, Cancer Res., 56, 988

Keppler, 1997, Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2, Biol. Chem., 378, 787

Versantvoort, 1995, On the relationship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP), Int. J. Cancer, 63, 855, 10.1002/ijc.2910630617

Versantvoort, 1995, Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein, Br. J. Cancer, 72, 82, 10.1038/bjc.1995.281

Feller, 1995, ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion, FEBS Lett., 368, 385, 10.1016/0014-5793(95)00677-2

Ishikawa, 1992, The ATP-dependent glutathione S-conjugate export pump, Trends Biochem. Sci., 17, 463, 10.1016/0968-0004(92)90489-V

Ishikawa, 1997, The GS-X pump in plant, yeast, and animal cells: structure, function, and gene expression, Biosci. Rep., 17, 189, 10.1023/A:1027385513483

Zaman, 1995, Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein, Proc. Natl. Acad. Sci. USA, 92, 7690, 10.1073/pnas.92.17.7690

Rappa, 1997, Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins, Cancer Res., 57, 5232

Twentyman, 1998, The influence of glutathione metabolism on multidrug resistance in MRP-overexpressing cells, Drug Resist. Updates, 1, 121, 10.1016/S1368-7646(98)80027-7

Loe, 1996, ATP-dependent 17 beta-estradiol 17-(beta-d-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids, J. Biol. Chem., 271, 9683, 10.1074/jbc.271.16.9683

Loe, 1998, Characterization of vincristine transport by the Mr 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione, Cancer Res., 58, 5130

Taguchi, 1997, Anti-cancer drugs and glutathione stimulate vanadate-induced trapping of nucleotide in multidrug resistance-associated protein (MRP), FEBS Lett., 401, 11, 10.1016/S0014-5793(96)01421-4

Flens, 1994, Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies, Cancer Res., 54, 4557

Zaman, 1994, The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump, Proc. Natl. Acad. Sci. USA, 91, 8822, 10.1073/pnas.91.19.8822

Evers, 1996, Basolateral localization and export activity of the human multidrug resistance-associated protein (MRP) in polarized pig kidney cells, J. Clin. Invest., 97, 1211, 10.1172/JCI118535

Schinkel, 1997, Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins, Proc. Natl. Acad. Sci. USA, 94, 4028, 10.1073/pnas.94.8.4028

Wijnholds, 1997, Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking MRP, Nat. Med., 11, 1275, 10.1038/nm1197-1275

Lorico, 1997, Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione, Cancer Res., 57, 5238

Oude Elferink, 1997, The role of mdr2 P-glycoprotein in hepatobiliary lipid transport, FASEB J., 11, 19, 10.1096/fasebj.11.1.9034162

Van Nieuwkerk, 1996, Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene, Gastroenterology, 111, 165, 10.1053/gast.1996.v111.pm8698195

De Vree, 1998, Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis, Proc. Natl. Acad. Sci. USA, 95, 282, 10.1073/pnas.95.1.282

Jacquemin, 1999, Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy, Lancet, 353, 210, 10.1016/S0140-6736(05)77221-4

Smith, 1998, Hepatocyte specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (−/−) mice, Hepatology, 28, 530, 10.1002/hep.510280234

Cohen, 1994, In vitro evidence that phospholipid secretion into bile may be coordinated intracellularly by the combined actions of bile salts and the specific phosphatidylcholine transfer protein of liver, Biochemistry, 33, 9975, 10.1021/bi00199a021

A. van Helvoort, A. De Brouwer, R. Ottenhof, J.F.H.M. Brouwers, J. Wijnholds, J.H. Beijnen, A. Rijneveld, T. Van der Poll, M.A. Van der Valk, D. Majoor, W. Voorhout, K.W.A. Wirtz, R.P.J. Oude Elferink, P. Borst, Mice without phosphatidylcholine transfer protein have no defects in secretion of phosphatidylcholine into bile or into the lung airspaces, Proc. Natl. Acad. Sci. USA (1999) accepted.

Crawford, 1997, Hepatic secretion of phospholipid vesicles critically depends on mdr2 or MDR3 P-glycoprotein expression, J. Clin. Invest., 100, 2562, 10.1172/JCI119799

Oude Elferink, 1998, Class III P-glycoproteins mediate the formation of lipoprotein X in the mouse, J. Clin. Invest., 102, 1749, 10.1172/JCI3597

Buschman, 1994, The inability of the mouse mdr2 gene to confer multidrug resistance is linked to reduced drug binding to the protein, Cancer Res., 54, 4892

A.J. Smith, A. van Helvoort, G. van Meer, A.H. Schinkel, P. Borst, K. Szabó, E. Welker, G. Szakács, A. Váradi, B. Sarkadi, MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping, J. Biol. Chem. (1999) submitted.

A.J. Smith, The Substrate Specificities of the Human MDR1 and MDR3 P-glycoproteins, Academic thesis, Universiteitsdrukkerij Grafische Dienst UvA, Amsterdam, 1998.

Szabó, 1998, Drug-stimulated nucleotide trapping in the human multidrug transporter MDR1. Cooperation of the nucleotide binding domains, J. Biol. Chem., 273, 10132, 10.1074/jbc.273.17.10132

Smit, 1994, Tissue distribution of the human MDR3 P-glycoprotein, Lab. Invest., 71, 638

W.P.Vermeulen, Mg2+-ATPase and Phospholipid Organization in the Erythrocyte Membrane, Academic thesis, University Utrecht, Utrecht, 1996.

J.W. Smit, Excretory Mechanisms for Cationic Drugs: Role of P-glycoprotein and Other Organic Cation Transporters, Academic thesis, Ponsen and Looijen BV, Wageningen, 1997.

Chollet, 1988, DNA containing the base analogue 2-aminoadenine: preparation, use as hybridization probes and cleavage by restriction endonucleases, Nucleic Acids Res., 16, 305, 10.1093/nar/16.1.305

Mayer, 1997, Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC 833, J. Clin. Invest., 100, 2430, 10.1172/JCI119784

Buschman, 1991, Functional analysis of chimeric genes obtained by exchanging homologous domains of the mouse mdr1 and mdr2 genes, Mol. Cell. Biol., 11, 595, 10.1128/MCB.11.2.595

Zhang, 1995, Functional evidence that transmembrane 12 and the loop between transmembrane 11 and 12 form part of the drug-binding domain in P-glycoprotein encoded by MDR1, J. Biol. Chem., 270, 5441, 10.1074/jbc.270.10.5441

Currier, 1992, Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1/MDR2 transporters, J. Biol. Chem., 267, 25153, 10.1016/S0021-9258(19)74018-6

Zhou, 1999, Studies of human MDR1-MDR2 chimeras demonstrate the functional exchangeability of a major transmembrane segment of the multidrug transporter and phosphatidylcholine flippase, Mol. Cell. Biol., 19, 1450, 10.1128/MCB.19.2.1450

van Helvoort, 1997, Transport of sphingomyelin to the cell surface is inhibited by brefeldin A and in mitosis, where C6-NBD-sphingomyelin is translocated across the plasma membrane by a multidrug transporter activity, J. Cell Sci., 110, 75, 10.1242/jcs.110.1.75

Raggers, 1999, The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane, J. Cell Sci., 112, 415, 10.1242/jcs.112.3.415

Kamp, 1998, Evidence for a role of the multidrug resistance protein (MRP) in the outward translocation of NBD-phospholipids in the erythrocyte membrane, Biochim. Biophys. Acta, 1372, 91, 10.1016/S0005-2736(98)00049-2

Dekkers, 1998, Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: outward-directed transport by the multidrug resistance protein 1 (MRP1), Biochemistry, 37, 14833, 10.1021/bi981011w

Decottignies, 1998, ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yorp1, J. Biol. Chem., 273, 12612, 10.1074/jbc.273.20.12612

Allikmets, 1997, A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy, Nat. Genet., 15, 236, 10.1038/ng0397-236

Illing, 1997, The 220-kDa rim protein of retinal rod outer segments is a member of the ABC transporter superfamily, J. Biol. Chem., 272, 10303, 10.1074/jbc.272.15.10303

Allikmets, 1997, Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration, Science, 277, 1805, 10.1126/science.277.5333.1805

Weng, 1999, Insights into the function of rim protein in photoreceptors and etiology of Stargardt’s disease from the phenotype in abcr knockout mice, Cell, 98, 13, 10.1016/S0092-8674(00)80602-9

Brooks-Wilson, 1999, Mutations in ABC1 in Tangier disease and familial high-density in lipoprotein deficiency, Nat. Genet., 22, 336, 10.1038/11905

Bodzioch, 1999, The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease, Nat. Genet., 22, 347, 10.1038/11914

Rust, 1999, Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1, Nat. Genet., 22, 352, 10.1038/11921

Young, 1999, The ABCs of cholesterol efflux, Nat. Genet., 22, 316, 10.1038/11878

Langmann, 1999, Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages, Biochem. Biophys. Res. Commun., 257, 29, 10.1006/bbrc.1999.0406

Luciani, 1994, Cloning of two novel ABC transporters mapping on human chromosome 9, Genomics, 21, 150, 10.1006/geno.1994.1237

Luciani, 1996, The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death, EMBO J., 15, 226, 10.1002/j.1460-2075.1996.tb00353.x

Becq, 1997, ABC1, an ATP binding cassette transporter required for phagocytosis of apoptotic cells, generates a regulated anion flux after expression in Xenopus laevis oocytes, J. Biol. Chem., 272, 2695, 10.1074/jbc.272.5.2695

Hamon, 1997, Interleukin-1beta secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1, Blood, 90, 2911, 10.1182/blood.V90.8.2911

Y. Hamon, M.-F. Luciani, A. Moynault, J.-M. Freyssinet, G. Chimini, Subcellular localization of the mammalian ABC transporter ABC1, Abstract Book 60, 1999.

G. Schmitz, J. Klucken, C. Büchler, G. Liebisch, W. Drobnik, M. Porsch-Ozcürümez, W.E. Kaminski, The human ATP-binding cassette transporter 8 (ABC8) is a cholesterol sensitive gene which is involved in macrophage cholesterol transport, Abstract Book 60, 1999.

Tang, 1996, A subfamily of P-type ATPases with aminophospholipid transporting activity, Science, 272, 1495, 10.1126/science.272.5267.1495

Siegmund, 1998, Loss of Drs2p does not abolish transfer of fluorescence-labeled phospholipids across the plasma membrane of Saccharomyces cerevisiae, J. Biol. Chem., 273, 34399, 10.1074/jbc.273.51.34399

E.H. Hettema, H.F. Tabak, Transport of fatty acids and metabolites across the peroxisomal membrane, Biochim. Biophys. Acta (1999) submitted.

Piper, 1998, The Pdr12 ABC transporter is required for the development of weak organic acid resistance in yeast, EMBO J., 17, 4257, 10.1093/emboj/17.15.4257

Borst, 1997, Genetic dissection of the function of mammalian P-glycoproteins, Trends Genet., 13, 217, 10.1016/S0168-9525(97)01112-8

Lincke, 1991, Structure of the human MDR3 gene and physical mapping of the human MDR locus, J. Biol. Chem., 266, 5303, 10.1016/S0021-9258(19)67788-4

Raymond, 1990, Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells, Mol. Cell. Biol., 10, 1642, 10.1128/MCB.10.4.1642

Schinkel, 1991, Multidrug resistance mediated by P-glycoproteins. [Review], Semin. Cancer Biol., 2, 213